5713-60-0

Basic information

• Product Name: 2-(1-benzothiophen-3-yl)-N,N-bis(2-chloroethyl)ethanamine
• CAS NO: 5713-60-0
• Molecular Formula: C₁₄H₁₇Cl₂NS
• Molecular Weight: 302.2625
• Mol File: 5713-60-0.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 368.4°C at 760 mmHg
• Flash Point: 176.6°C
• Density: 1.249g/cm³
• Vapor Pressure: 1.27E-05mmHg at 25°C
• Refractive Index: 1.611
• CAS DataBase Reference: 2-(1-benzothiophen-3-yl)-N,N-bis(2-chloroethyl)ethanamine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(1-benzothiophen-3-yl)-N,N-bis(2-chloroethyl)ethanamine(5713-60-0)
• EPA Substance Registry System: 2-(1-benzothiophen-3-yl)-N,N-bis(2-chloroethyl)ethanamine(5713-60-0)

Safety Data

• Hazardous Substances Data: 5713-60-0(Hazardous Substances Data)

Usage

Description

2-(1-benzothiophen-3-yl)-N,N-bis(2-chloroethyl)ethanamine is a chemical compound characterized by the presence of a benzothiophene ring and two chloroethyl groups attached to an ethanamine backbone. This structure endows it with alkylating properties, which are crucial for its applications in cancer therapy.

Uses

Used in Cancer Therapy:
2-(1-benzothiophen-3-yl)-N,N-bis(2-chloroethyl)ethanamine is used as an alkylating agent for cancer treatment. Its ability to add alkyl groups to DNA results in the inhibition of DNA replication, thereby inducing cell death. This mechanism is particularly effective against rapidly dividing cells, such as those found in cancerous tumors.
Used in Oncology Research:
In the field of oncology, 2-(1-benzothiophen-3-yl)-N,N-bis(2-chloroethyl)ethanamine is used as a research tool to study the effects of alkylating agents on various types of cancer cells. Its potential applications are being explored for the treatment of different cancer types, including lymphoma and leukemia.
Used in Pharmaceutical Development:
2-(1-benzothiophen-3-yl)-N,N-bis(2-chloroethyl)ethanamine is also utilized in the development of pharmaceutical drugs targeting cancer. Its unique structure and alkylating capabilities make it a promising candidate for the creation of novel therapeutic agents that can combat cancer more effectively and with fewer side effects.
Used in Drug Delivery Systems:
To enhance the efficacy and targeted delivery of 2-(1-benzothiophen-3-yl)-N,N-bis(2-chloroethyl)ethanamine, it is being incorporated into various drug delivery systems. These systems aim to improve the bioavailability and therapeutic outcomes of the compound, ensuring that it reaches cancer cells with precision while minimizing damage to healthy cells.